Barclays raises target for Illumina stock to USD 200.00
Published on 10/08/2026 at 13:50 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Illumina Inc. (ISIN US4523271090) was at EUR 236.88 at Lang & Schwarz on October 8, 2026 at 1:39 p.m. CEST, up 0.12 percent versus the EUR 236.60 prior close. According to Moomoo on October 7, 2026, Barclays maintained a sell rating while raising its target from USD 160.00 to USD 200.00.
Analysts reset the valuation bar
The Barclays move is a sharper valuation signal than the target increase alone. The new USD 200.00 target remains below the average 12-month target of USD 219.69, while the consensus rating consists of 10 buys, six holds and two sells, according to MarketBeat on October 7, 2026.
Three dated signals from 2026
On September 9, 2026, UBS raised its target from USD 135.00 to USD 260.00 and upgraded Illumina from neutral to buy, according to MarketBeat. On September 28, 2026, Piper Sandler lifted its target from USD 225.00 to USD 305.00 and kept an overweight rating, the same source reported. On October 7, 2026, Barclays raised its target from USD 160.00 to USD 200.00 while retaining a sell rating, as Moomoo reported.
What does the target reset imply?
Illumina's operating picture improved in the second quarter of fiscal 2026. Revenue reached USD 1.159 billion, up 9.5 percent from the prior-year quarter, while GAAP operating margin rose to 21.1 percent from 20.2 percent, according to Illumina in its July 30, 2026 results release.
Management raised fiscal 2026 total revenue guidance to USD 4.60 billion to USD 4.64 billion from USD 4.52 billion to USD 4.62 billion. Non-GAAP diluted earnings per share guidance moved to USD 5.30 to USD 5.40 from USD 5.15 to USD 5.30, creating a stronger operating backdrop even as Barclays kept a more cautious valuation view.
Next company date
Illumina lists a webinar for November 13, 2026, giving investors a dated product and technology event after the second-quarter report.
Stock holds near its yearly range
At EUR 236.88, the Lang & Schwarz price stood below the primary-market 52-week high of USD 309.35 and above the USD 88.00 low reported for NASDAQ on October 7, 2026. Illumina's market capitalization was USD 40.5 billion on October 8, 2026, according to the finance quote, while the stock was at EUR 236.88 at Lang & Schwarz at 1:39 p.m. CEST, plus 0.12 percent versus the EUR 236.60 prior close of October 7, 2026. The further course of trading is shown by the continuously updated real-time quote of Illumina stock.
Illumina stock facts
- Company: Illumina, Inc.
- ISIN: US4523271090
- Ticker: ILMN
- Primary exchange: NASDAQ
- Price Lang & Schwarz as of October 8, 2026 at 1:39 p.m. CEST: EUR 236.88
- Change versus prior close: plus 0.12 percent
- Prior close Lang & Schwarz October 7, 2026: EUR 236.60
- Market capitalization: USD 40.5 billion as of October 8, 2026
- 52-week range: USD 88.00-309.35 as of October 7, 2026
- Sector / Industry: Healthcare / Medical diagnostics and research
- Index membership: S&P 500
Market context: Market report S&P 500.
